More recently MCL-1 and BCL-2 inhibitors were shown to induce apoptosis of Mtb-infected macrophages suggesting that targeting the intrinsic apoptosis pathway is a valid approach for TB host-directed therapy.48 Here, MCL1 is linked to tuberculosis.